STOCK TITAN

National Vision Holdings, Inc. SEC Filings

EYE NASDAQ

Welcome to our dedicated page for National Vision Holdings SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on National Vision Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into National Vision Holdings's regulatory disclosures and financial reporting.

Rhea-AI Summary

The Vanguard Group filed an amendment to its Schedule 13G/A reporting for National Vision Holdings Inc. The amendment states Amount beneficially owned: 0 and Percent of class: 0%. It explains an internal realignment effective January 12, 2026 leading certain subsidiaries to report separately. The filing is signed by Ashley Grim on 03/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

National Vision Holdings, Inc. director and Chief Executive Officer Alexander Wilkes reported an open-market sale of 35,000 shares of common stock on March 11, 2026 at a weighted average price of $26.54 per share, in multiple trades between $26.21 and $26.91.

The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on December 5, 2025, indicating it was pre-scheduled. Following this sale, Wilkes directly holds 16,431 shares of National Vision common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

EyePoint Pharmaceuticals notified the SEC of a proposed sale of 35,000 shares of Common Stock via Fidelity Brokerage Services LLC, with an aggregate value of $955,500.00, filed on 03/11/2026. The filing lists 34,242 shares from restricted stock vesting (08/19/2025) and 758 shares from an ESPP purchase (11/28/2025). Shares outstanding were 79,437,185 as of 03/11/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

National Vision Holdings, Inc. reported that Chief Technology Officer David G. Cutler acquired 10,753 restricted stock units as a grant or award. Each restricted stock unit converts into one share of common stock. Following this grant, he holds 36,750 restricted stock units directly.

According to the disclosure, one-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026, aligning compensation with longer-term company performance and retention incentives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

National Vision Holdings, Inc. reported that senior vice president Ana Moeddel received a grant of 10,753 restricted stock units on March 6, 2026. Each restricted stock unit converts into one share of common stock. One-third of these units will vest on each anniversary of the March 6, 2026 grant date.

After this award, Moeddel directly holds 44,938 restricted stock units. These equity awards form part of her compensation and may increase her alignment with shareholder interests as the units vest over time and convert into common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

National Vision Holdings, Inc. executive Priti V. Patel, Head of Emerging Brands, reported equity compensation activity involving restricted stock units and common stock. On March 6, 2026, 8,224 restricted stock units were exercised and converted into 8,224 shares of common stock, consistent with the one-for-one RSU conversion described.

Patel also received a new grant of 10,753 restricted stock units on the same date. In connection with RSU vesting, 2,738 shares of common stock were disposed of at $27.90 per share to satisfy tax withholding obligations, as noted in the footnotes. After these transactions, Patel directly held 30,892 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

National Vision Holdings Chief Brand & Marketing Officer Joseph VanDette reported equity award activity and related tax withholding. On March 6, 2026, 8,224 restricted stock units converted into an equal number of common shares, and he received a grant of 10,753 additional restricted stock units.

After these transactions, he directly owned 48,502 shares of common stock before tax withholding. To satisfy tax obligations tied to vesting, 2,430 common shares were withheld at a price of $27.90 per share, leaving 46,072 common shares owned directly. Following the new award, he held 30,565 restricted stock units in total.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

National Vision Holdings executive Mark Banner reported equity compensation activity. On March 6, 2026, 13,706 restricted stock units converted into the same number of common shares at no cost, and he received a new award of 10,753 restricted stock units. To cover tax withholding on vesting, 4,133 common shares were disposed of at $27.90 per share. After these transactions, he directly held 17,839 shares of common stock and 61,622 restricted stock units, which convert into common stock on a one-for-one basis. Footnotes indicate these units come from a 41,119-unit grant dated March 7, 2025 that vests in three equal installments starting on the first anniversary of the grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

National Vision Holdings, Inc. Chief People Officer Bill Clark reported equity compensation activity involving restricted stock units and common stock. On March 6, 2026, 8,224 restricted stock units were exercised into common stock at no cost, and he received a new grant of 10,753 restricted stock units. Following these awards, he directly held 30,565 restricted stock units. The restricted stock units convert into common stock on a one-for-one basis and vest in three equal annual installments starting on the first anniversary of the grant date.

On the same date, 2,430 shares of common stock valued at $27.90 per share were disposed of to cover tax liabilities associated with the vesting, rather than through an open-market sale. After these transactions, Clark directly owned 70,218 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

National Vision Holdings, Inc. Chief Legal & Strategy Officer Jared Brandman reported equity award activity involving restricted stock units and common stock. On March 6, 2026, restricted stock units covering 10,279 shares were exercised and converted into common stock on a one-for-one basis, and he received an additional grant of 10,753 restricted stock units. In connection with the RSU vesting, 3,494 common shares at $27.90 per share were withheld to cover tax liabilities, a disposition that did not represent an open-market sale. Following these transactions, Brandman directly owned 76,031 shares of common stock and 38,634 restricted stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many National Vision Holdings (EYE) SEC filings are available on StockTitan?

StockTitan tracks 77 SEC filings for National Vision Holdings (EYE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for National Vision Holdings (EYE)?

The most recent SEC filing for National Vision Holdings (EYE) was filed on March 27, 2026.